Leadership: Page 2


  • Image attribution tooltip

    Permission granted by Michelle Keefe. 

    Q&A

    First 90 Days: Syneos Health's Michelle Keefe

    The newly minted CEO is leaning on her 30 years of experience leading high-performance teams to make her mark at Syneos.

    By May 23, 2022
  • Image attribution tooltip
    Permission granted by Vidya Viswanathan

    Tracking trends in healthcare, from tech to patient care

    High-performing leaders honored by the Healthcare Businesswomen’s Association share their views on the future of the industry.

    By May 20, 2022
  • Image attribution tooltip
    iStock via Getty Images
    Q&A

    Ironwood Pharmaceuticals is charting a course to become a giant in GI

    Ironwood’s CEO, Tom McCourt, discusses the company’s strategy for leveling up in the GI market. 

    By May 19, 2022
  • Image attribution tooltip
    Retrieved from Diego Camargo/PharmaVoice on May 17, 2022
    Podcast

    Woman of the Week: Sparrow Pharmaceuticals' Jamie MacPherson

    The vice president of regulatory affairs and quality on embracing leadership challenges in drug development.

    By May 18, 2022
  • Image attribution tooltip
    Permission granted by SpringWorks/Jim Cassidy
    Profile

    Jumping into pharma with big plans at a small company

    SpringWorks Therapeutics' chief medical officer on the ambition that drives him and his company to develop treatments for cancer patients.

    By Alexandra Pecci • May 17, 2022
  • Image attribution tooltip

    Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma and one of this year's HBA Luminary honorees. 

    Opinion

    Why 'soft' skills matter in the new era of leadership

    Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.

    By May 12, 2022
  • Image attribution tooltip
    Permission granted by TauRx
    Profile

    With the shine of amyloid fading, tau is a rising star in Alzheimer's

    The tau theory in Alzheimer's is being put to the test with phase 3 trial results due later this month from TauRx Pharmaceuticals.

    By May 11, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: AiCure's Michelle Marlborough

    As chief product officer at AiCure, Michelle Marlborough is focused on solving tough patient challenges through technology.

    By May 11, 2022
  • Image attribution tooltip
    Permission granted by Replimune/Philip Astley-Sparke

    Where hope and uncertainty meet: A cutting-edge cancer developer's winding road

    Replimune is on the precipice of a new kind of cancer treatment, but its CEO knows something about ambiguity.

    By Alexandra Pecci • May 9, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Amgen's Dr. Jane Parnes

    As executive medical director, early development at Amgen, Dr. Jane Parnes has helped guide clinical research for upwards of 30 of the company’s investigational molecules, including the newly approved Tezspire for severe asthma — one of her career highlights.

    By May 4, 2022
  • Image attribution tooltip

    Permission granted by Nelson Ambrogio.

    Profile

    Bayer executive makes strides toward a finish line for rare cancers

    Bayer's SVP and general manager of U.S. oncology completed the Boston Marathon to honor his brother and bring attention to rare cancers.

    By Alexandra Pecci • May 3, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    One company's failed drug is this company's 'jewel'

    Dr. Thomas Bock, CEO of Notable, is helping the company develop a ‘new class’ of predictive precision medicines in oncology.

    By May 2, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Gilead Science's Dr. Shanthi Ganeshan

    As vice president of Global Regulatory Affairs, Oncology at Gilead, Ganeshan says there’s ‘never a dull moment’ in the quest to deliver therapies to patients.

    By April 27, 2022
  • Image attribution tooltip
    D-Keine via Getty Images
    Profile

    Mouse vs. machine: Using AI to solve the animal testing model in pharma

    Quris is bringing its first drug tested preclinically using AI — rather than animal models — into human trials.

    By April 26, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Aura Biosciences' Dr. Elisabet de los Pinos

    Dr. Elizabet de los Pinos, CEO and founder of Aura Biosciences, had a dream at a young age to change the course of cancer treatment and understand the underlying DNA of the disease.

    By April 20, 2022
  • Image attribution tooltip
    Permission granted by Entos/Steve Chen
    Profile

    With Lilly on board, Entos' medical chief champions genetic platform with 'unlimited' potential

     Steve Chen is helping to lead Entos through an ‘inflection point’ in the development of its precision medicine delivery platform.

    By Alexandra Pecci • April 14, 2022
  • Image attribution tooltip
    Yongyuan via Getty Images
    Q&A

    Biotech goes Hollywood

    A few years ago, the biotech venture world in LA was almost ‘nonexistent’ — now Joseph Panetta, CEO of Biocom California, says the region is undergoing a major change.

    By April 13, 2022
  • Image attribution tooltip
    Kenny Holston via Getty Images

    Why the war in Ukraine could accelerate the deglobalization of clinical trials

    COVID slowed many studies — but the war could further strain clinical trials worldwide.

    By April 12, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Lyell Immunopharma's Liz Homans

    The CEO has the company poised to capitalize on its moment to address T cell exhaustion.

    By April 6, 2022
  • Image attribution tooltip
    iStock via Getty Images

    A planned trial revives a glimmer of hope for a Huntington's disease treatment

    Roche brought a Huntington’s drug back to life after a jarring trial halt.

    By Kelly Bilodeau • April 6, 2022
  • Image attribution tooltip
    Permission granted by Alnylam/Yvonne Greenstreet
    Profile

    Seeing yourself at the top: Alnylam CEO on why representation matters

    Dr. Yvonne Greenstreet became just the sixth woman in the world to head up a biopharma company with a market cap of more than $5 billion when she took on the role of CEO in January.

    By Alexandra Pecci • April 6, 2022
  • Image attribution tooltip

    Permission granted by Apurva Saraf. 

    An analyst turned pharma CEO learns the art of operations

    Under Apurva Saraf’s guidance, Cosette Pharmaceuticals is pivoting wholeheartedly into the cardio space.

    By Jared Whitlock • April 5, 2022
  • Image attribution tooltip
    Real Chemistry/PharmaVoice
    Q&A

    Lessons from improv: Shankar Narayanan's 'yes, and' approach to healthcare leadership

    Real Chemistry's CEO is bringing a unique set of skills to the role as he sets off on a company-wide listening tour.

    By April 4, 2022
  • Image attribution tooltip

    Sangamo Therapeutics

    Q&A

    Sangamo has its finger on the next evolution of gene editing

    Sangamo Therapeutics' CEO Sandy Macrae is bullish on his company’s ability to transform the genomic medicine arena.

    By March 31, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Daré Bioscience's Sabrina Martucci Johnson

    The CEO is setting a path to transform women’s health at an opportune time.

    By March 30, 2022